Hematology & Medical Oncology Chief Fellows 2022-2023
Dear Colleagues, We are extremely excited to announce that Dr. Michelle Lee and Dr. Hamza Hassan have accepted Chief Fellow positions for the 2022-2023 year. They have big shoes to fill as Dr. Karen Axten and Dr. Andrew Staron have done a fantastic job this year supporting not only each other but their Fellow colleagues […]
Naomi Ko, MD, MPH, AM, Awarded Leonard Tow Humanism in Medicine Award from BUSM
Congratulations to Naomi Ko, MD, MPH, AM, for being awarded the Leonard Tow Humanism in Medicine Award from the Boston University School of Medicine. This important award recognizes faculty who “demonstrate both clinical excellence and outstanding compassion in the delivery of care and who show respect for patients and their families as well as healthcare […]
Professor David Chui, MD, FRCPC, Retiring from Boston University School of Medicine and Boston Medical Center
Dear Colleagues, It is with mixed emotions that I am writing to let you know that Professor David Chui, MD, FRCPC will be retiring from Boston University School of Medicine and Boston Medical Center. Dr. Chui is an internationally recognized figure in the fields of hematology and sickle cell disease, where he has made fundamental […]
Jan 22 Section Newsletter
Hem-Onc Section Newsletter-January 2022
February 22 Active Cancer Clinical Trials
February 22 Cancer Clinical Trials Brochure
BMC Cancer Research Innovator Award Recipients
Congratulations to the recipients of the BMC Cancer Research Innovator Awards, a new research grant program to support junior faculty at the beginning of their careers who are performing innovative research in cancer and areas related to cancer. Award funding is for one year in the amount of $50,000. Hussein Assi, MD Assistant Professor, […]
December 21 Section Newsletter
Hem Onc Section Newsletter-December 21
Beyond Survival in AL amyloidosis: Identifying and Satisfying Patients’ Needs
Beyond Survival in AL amyloidosis: Identifying and Satisfying Patients’ Needs
Racial disparities a ‘harsh reality’ in breast cancer care
Phase 1a/b study of monoclonal antibody CAEL-101 (11-1F4) in patients with AL amyloidosis
Camille Edwards, M.D., et al. Phase 1a/b study of monoclonal antibody CAEL-101 (11-1F4) in patients with AL amyloidosis